Global Structural Heart Devices Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2027

MarketResearch.biz delivers in-depth insights on the global structural heart devices market in its upcoming report titled, “Global Structural Heart Devices Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2027”. The global structural heart devices market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global structural heart devices market report has been segmented on the basis of product type, indication, end user, and region.

This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.

Structural heart devices are used for the treatment of various heart diseases. Structural heart diseases refer to cardiac defects, that are congenital in nature and also involves abnormalities developed in the valves and vessels of heart caused by wear or tear because of some disease. In addition, structural heart diseases are non-coronary irregularity of the heart, that will not affect blood vessels in heart. Moreover, common structural heart condition involves patent foramen oval, atrial septal defect, ventricular septal defect, arterial/venous fistulae, paravalvular leak, and congenital heart disease.

Increasing incidence of aortic stenosis and introduction of technologically advanced products, and increasing awareness about benefits and availability of structural heart devices across the globe are major factors expected to drive growth of the global structural heart devices market. Moreover, increasing number of end-use applications, coupled with its rising adoption of tissue valves and annuloplasty rings are other factors expected to fuel growth of the global structural heart devices market. However, stringent government regulation and high cost of surgeries are major factors expected to restrict growth of the global structural heart devices market to certain extent.

North America structural heart devices market is estimated to account for major share in terms of revenue in the global structural heart devices market. Asia Pacific structural heart devices market is anticipated to register fastest growth in terms of revenue over the next 10 years, owing to increasing demand from the healthcare industry in countries in this region. China market is estimated to account for significant share in terms of revenue in the Asia Pacific, whereas the structural heart devices market in India is anticipated to register highest CAGR over the forecast period. Rising awareness regarding various chronic deceases in general population and rapid growth in urban and rural regions in this region are other major factors fueling growth of healthcare industry, which in turn is expected to fuel growth of the structural heart devices market in this region.

Global Structural Heart Devices Market Segmentation:

Segmentation by product type:

• Heart Valve
  • Transcatheter Heart Valve
  • Mechanical Heart Valve
  • Surgical Heart Valve
• Annuloplasty rings
• Occlusion Devices

Segmentation by indication:

• Valvular Heart Disease
  • Regurgitation
  • Stenosis
• Cardiomyopathy
• Congenital Heart Defects

Segmentation by end user:

• Hospitals
• Ambulatory Surgical Centers

Segmentation by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa